Bullish Stocks That Recorded 52 Week Highs: $CSTL $NUS $MMSI

The Market Signal was created as a platform to help investors, if you own (NASDAQ:CSTL), (NYSE:NUS) or (NASDAQ:MMSI) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)

Castle Biosciences is bullish on new of commercialization of DecisionDx(R)-SCC

https://themarketsignal.com/Free-Report/CSTL

(Click link above or copy, paste and hit enter in your browser for your report)

Castle Biosciences Inc. (NASDAQ:CSTL) hit a new 52-week high of $50.09

Castle Biosciences, Inc. (Nasdaq: CSTL) has started commercialization of DecisionDx(R)-SCC, its prognostic gene expression profile test used to treat high-risk cutaneous squamous cell carcinoma (SCC). The DecisionDx-SCC test is used to classify patients into risk categories using a neural network algorithm.

The company conducted independent validation for the drug in a prospectively designed, multi-center (33 sites) study.

Nu Skin Enterprises is trending following strong revenue in Q2 2020

https://themarketsignal.com/Free-Report/NUS

(Click link above or copy, paste and hit enter in your browser for your report)

Nu Skin Enterprises, Inc. (NYSE:NUS) hit a new 52-week high of $49.76

Merit Medical Systems is bullish following sale of manufacturing equipment to Freudenberg Medical

https://themarketsignal.com/Free-Report/MMSI

(Click link above or copy, paste and hit enter in your browser for your report)

Merit Medical Systems, Inc. (NASDAQ:MMSI) hit a new 52-week high of $49.60

Freudenberg Medical has acquired the dedicated manufacturing equipment and associated assets used by Merit Medical Systems, Inc. The assets are used in the hypotube manufacturing business. Freudenberg Medical specialises in the development and manufacture of specialty components and finished products for the medical device industry.

The purchased assets will be installed at Freudenberg Medical company's Cambus Medical situated in Galway, Ireland. Cambus Medical. Cambus Medical was established in 2006 and specialises in the development and production of hypotubes, specialty needles, and metal micro-components.

Among other assets acquired include manufacturing equipment for laser-cut hypotubes and access to additional technology. In addition, Merit Medical will also supply PTFE coated tubing and wire to help Cambus Medical maintain its supply chain.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

comtex tracking

COMTEX_371058197/2705/2020-09-10T06:46:10

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.